The selling pressure regarding Roche Holding Ltd. shares could subside shortly. In fact, the support area that is currently being tested around 232.7 CHF has come into play and could, at least in the short term, keep the downside pressure at bay. Investors have an opportunity to buy the stock and target the CHF 243.
The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at CHF 233.2 CHF in weekly data.
The close medium term support offers good timing for purchasing the stock.
Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
The company is in a robust financial situation considering its net cash and margin position.
This company will be of major interest to investors in search of a high dividend stock.
Analysts covering this company mostly recommend stock overweighting or purchase.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
The company's enterprise value to sales, at 4.1 times its current sales, is high.
For the past seven days, analysts have been lowering their EPS expectations for the company.
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.